Page results
-
Professor David Choi is a consultant neurosurgeon. He sees patients with common conditions such as back and neck pain, disc problems, nerve root impingement, through to complex problems of spine and skull base tumours, endoscopic and craniocervical junction surgery.
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
-
The plasma exchange service at the National Hospital treats patients with neuroimmunological diseases such as Guillain-Barré syndrome and myasthenia gravis.
-
The Lysholm Department of Neuroradiology is a multidisciplinary team of healthcare professionals providing leading-edge neuroradiological services, performing around 60,000 examinations and procedures per year.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
The clinical management of neuromuscular muscle wasting diseases such as motor neuron disease, myasthenia gravis, muscular dystrophy and peripheral neuropathy.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided cervical (neck) and lumbar (lower back) nerve root injections to patients referred by the Camden community MSK services.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided cervical (neck) and lumbar (lower back) facet joint injections to patients referred by the Camden community MSK services.
-
The Acute Stroke Unit (ASU) is the next step of care for stroke patients who come to the Hyper-acute Stroke Unit (HASU) at UCLH.
-
This page provides information for employers, teachers, special needs education coordinators (SENCo) and other professionals who work alongside someone with Galactosaemia.
File results
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment